These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36049962)

  • 21. Type 2 diabetes mellitus in heterozygous familial hypercholesterolaemia: the hazardous intersection of cardiometabolic and genetic risk.
    German CA; Shapiro MD
    Eur J Prev Cardiol; 2022 Jan; 28(16):1817-1818. PubMed ID: 33961017
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment gaps and mortality among patients with familial hypercholesterolemia and cardiovascular disease: a 4-year follow-up study.
    Shemesh E; Azaiza A; Zafrir B
    Eur J Prev Cardiol; 2021 Jul; 28(8):e21-e22. PubMed ID: 32539452
    [No Abstract]   [Full Text] [Related]  

  • 24. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
    Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S;
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Familial hypercholesterolemia].
    Windler E; Beil FU; Altenburg C; Rinninger F
    Dtsch Med Wochenschr; 2012 Nov; 137(46):2375-9. PubMed ID: 23132157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
    Miname MH; Santos RD
    Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
    Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
    Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
    Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
    Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyvascular subclinical atherosclerosis in familial hypercholesterolemia: The role of cholesterol burden and gender.
    Mattina A; Giammanco A; Giral P; Rosenbaum D; Carrié A; Cluzel P; Redheuil A; Bittar R; Béliard S; Noto D; Quartarone A; Averna M; Bruckert É; Gallo A
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1068-1076. PubMed ID: 31378630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two forms of familial hypercholesterolemia: differences in cardiovascular risk factors, cardiac and extracardiac atherosclerosis].
    Vogt A; Keller C; Heigl C; Weiss N; Zöllner N
    Dtsch Med Wochenschr; 2014 Dec; 139(50):2573-7. PubMed ID: 25126774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
    Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Garoufi A; Lambadiari V; Dima I; Kiouri E; Agapakis D; Zacharis E; Antza C; Kolovou V; Koumaras C; Bantouvakis G; Liamis G; Liberopoulos EN
    Endocrine; 2022 May; 76(2):324-330. PubMed ID: 35262845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response by Paquette and Baass to Letter Regarding Article, "Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia".
    Paquette M; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):e526-e527. PubMed ID: 34813347
    [No Abstract]   [Full Text] [Related]  

  • 33. Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges.
    Banderali G; Capra ME; Biasucci G; Stracquadaino R; Viggiano C; Pederiva C
    Ital J Pediatr; 2022 Jul; 48(1):115. PubMed ID: 35840982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter by Romero-Jiménez et al Regarding Article, "Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia".
    Romero-Jiménez MJ; Castaño MÁ; Mansilla ME; Mata P
    Arterioscler Thromb Vasc Biol; 2021 Dec; 41(12):e524-e525. PubMed ID: 34813346
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial hypercholesterolemia.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K; Harada-Shiba M; Arai H; Bujo H; Nohara A; Ohta T; Oikawa S; Okada T; Wakatsuki A
    J Atheroscler Thromb; 2014; 21(1):6-10. PubMed ID: 24335046
    [No Abstract]   [Full Text] [Related]  

  • 36. LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia.
    Aledo R; Alonso R; Mata P; Llorente-Cortés V; Padró T; Badimon L
    Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):807-12. PubMed ID: 22819221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated.
    Stock J
    Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884
    [No Abstract]   [Full Text] [Related]  

  • 38. Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography.
    Lee WJ; Chuang HN; Chen YM; Liang KW; Tung H; Chen JP; Lee IT; Wang JS; Lin CH; Lin HJ; Sheu WH; Lee WL; Hsiao TH
    Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein (a) in familial hypercholesterolaemia.
    Durrington PN; Bashir B; Bhatnagar D; Soran H
    Curr Opin Lipidol; 2022 Aug; 33(4):257-263. PubMed ID: 35942820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.